ENTITY

Verici Dx (VRCI LN)

1
Analysis
Health Care • United States
Verici Dx is an immuno-diagnostics development company focused on prognostic and diagnostic tests for kidney transplant patients. The company develops a suite of proprietary tests including Clarava, Tuteva, and Protega, utilizing AI-assisted transcriptomic analysis to provide RNA signatures for personalized patient and organ response risk. Verici Dx was founded in 2020 and is headquartered in Cardiff, United Kingdom.
more
Company Event • 01 Oct 2026 00:30 • Upcoming
Add To Calendar

H1 2026

Company Event • 16 Jul 2024 23:30 • Latest

H1 2024

Company Event • 05 Oct 2023 23:30

H1 2023

Company Event • 25 May 2022 23:30

H2 2021

No more events
x